Longboard Pharmaceuticals (LBPH) Financials

$59.98

$0.00 (0.00%)

As on 13-Dec-2024 09:30EDT

Market cap

$2,342 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

8.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	0.01	--	--	--	--	--
Cost of Revenue	0.00	0.01	0.01	0.00	--	--
Gross Profit	0.00	-0.01	-0.01	0.00	--	--
Operating Expenses	87.45	56.76	44.80	27.84	14.40	--
Operating Profit (EBIT)	-87.45	-56.76	-44.80	-27.84	-14.40	--
Other Income	--	--	-0.53	--	--	--
Profit before Tax	-76.34	-54.42	-43.95	-27.80	-14.40	--
Provision for Tax	-0.61	--	-0.85	-0.06	-0.01	--
Profit after Tax (Net Income)	-76.34	-54.42	-43.09	-27.73	-14.40	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-43.95	-27.80	-14.40	--

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	275.19	40.92	61.47	103.32	53.10	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	3.47	--	0.38	0.19	55.80	--
Current Liabilities	18.35	9.77	8.76	5.44	3.14	--
Total Liabilities	315.36	50.70	70.62	108.95	56.24	--

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	3.98	0.48	0.78	0.57	0.88	--
Current Assets	293.03	50.22	69.84	108.38	55.36	--
Total Assets	590.04	50.70	70.62	108.95	56.24	--
Total Debt*	3.73	0.48	0.74	0.52	--	--
Net Current Assets	--	40.45	61.07	102.94	52.23	--

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-50.87	-38.06	-24.71	-3.44	--
Cash Flow from Investing Activities	--	--	-17.06	-40.72	-40.72	--
Cash from Financing Activities	--	30.19	-0.44	76.45	58.76	--
Net Cash Inflow / Outflow	--	--	-55.57	--	--	--

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	-2.24	-2.27	-2.50	-1.63	-0.85	--
Cash EPS ($)	--	-2.27	-2.50	-1.63	-0.85	--
Adjusted Book Value ($)	--	1.71	3.57	6.07	3.14	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.13	-2.21	-1.45	-0.20	--
Free Cash Flow per Share ($)	--	-2.13	-2.21	-1.45	-0.20	--

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-105.05	-51.90	-35.34	--	--
ROE (%)	-25.93	-106.30	-52.30	-35.46	--	--
ROA (%)	-23.29	-89.72	-48.00	-33.58	--	--
EBIT Margin (%)	-1,093,125.00	--	--	--	--	--
Net Margin (%)	-954,300.00	--	8,161.36	--	--	--
Cash Profit Margin (%)	-238.58	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-65.27	-26.70	-60.92	-93.33	--	--
Net Profit Growth (%)	-53.16	-26.29	-55.38	-92.59	--	--
EPS Growth (%)	5.65	0.09	-0.54	-0.91	--	--
Book Value Growth (%)	218.79	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	-2.65	-1.30	-3.00	--	--
Price / Book Value	8.51	3.53	0.91	0.80	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-12.30	-1.70	0.24	0.83	--	--
Close Price ($)	33.33	6.03	3.26	4.88	--	--
High Price ($)	40.48	10.29	6.47	18.95	--	--
Low Price ($)	3.60	3.16	2.70	4.70	--	--
Market Cap ($ Cr)	2,341.96	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	0.01	0.01	0.01	--	--
Short term debt to equity ratio	0.00	0.01	0.01	0.00	--	--
Current Ratio	15.97	5.14	7.97	19.91	17.66	--
Quick Ratio	15.97	--	--	--	--	--
Interest Coverage	-149.88	--	-53.52	-662.83	--	--

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	0.00	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	84,409.28	85,395.45	409,262.63	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.